"We are an ophthalmic surgical and ocular disease specialty clinic striving to serve patients and our colleagues throughout the Kansas City region."

During the past decade, Moyes Eye Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Moyes Eye Center" are "Dry Eye Syndromes" (3 trials), "Ocular Hypertension" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials) and "Dry Eye Disease" (1 trials). Many other conditions were trialed in "Moyes Eye Center" in a lesser frequency.

Most popular intervention types in "Moyes Eye Center" are "Drug" (11 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Vehicle" (3 trials), "PVP-I 0.6%" (2 trials), "Placebo" (2 trials), "SHP640" (2 trials) and "011516X (New Artificial Tear Formulation)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Moyes Eye Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Moyes Eye Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Moyes Eye Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Moyes Eye Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".